ClinicalTrials.gg
RecruitingNCT06628908Updated Oct 15, 2026

Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

A Phase 3 interventional study of Suzetrigine and Placebo (matched to SUZ) in Diabetic Peripheral Neuropathic Pain, sponsored by Vertex Pharmaceuticals Incorporated. Recruiting at 76 sites in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-10-15.

Sponsored by Vertex Pharmaceuticals Incorporated · Phase 3, Interventional, and Treatment

From the registry’s dates

  • Started Oct 2024; still recruiting 2 years 1 month later.
Updated Oct 15, 2026Site recruiting status changedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
1,100
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 291 studies in Neuralgia with a site in United States — 50 open to participants now, 61 under way, 5 of them phase 3. Neuralgia · United States.

Planned enrollment
2nd of 261
1,100 · median 40
Started
2024
with 17 others
Phase 3
22 of 291
3 open now
Primary completion
2027-05
later than 30 of 60 live
Registered
261st of 291
by date

Among the 291 studies in Neuralgia with a site in United States, this one is the 2nd largest by planned enrollment of the 261 interventional ones that give a count, is one of 18 that started in 2024, is one of 22 in phase 3, reaches primary completion later than 30 of the 60 other live ones, and was the 261st registered.

Neuralgia

1,102 studies on the registry are indexed under Neuralgia; 242 are open to participants now.

Browse Neuralgia studies →

Open to participants now

50 of the 291 studies in Neuralgia with a site in United States are open now. Recruiting first, the newest first:

44 more — sign in →

All 50 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 153 Neuralgia studies recruiting now, 77 (50%) set no upper age limit and 44 (29%) stop at 75 or younger; 8 take children under 18; 12 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 291 studies in Neuralgia with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabetic peripheral neuropathy (DPN).

03

Conditions studied

  • Diabetic Peripheral Neuropathic Pain

Browse trials for

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Key Inclusion Criteria:

  • Body weight greater than or equal to (≥) 45 kilogram (kg)
  • (BMI) ≥18.0 to less than (\<) 40.0 kilogram per meter square (kg/m\^2)
  • Diagnosis of diabetes mellitus type 1 or type 2 by glycosylated (HbA1c) ≤9% and the presence of bilateral pain in lower extremities due to DPN
  • Weekly average of daily NPRS score ≥4 and less than or equal to (≤) 9 with limited variation in the 7-day Baseline Period

Key Exclusion Criteria:

  • More than 3 missing daily NPRS scores during the 7-day Baseline Period
  • Any sensory abnormality (excluding DPN) as pre-specified in the protocol

Other protocol defined Inclusion/Exclusion criteria may apply.

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

HbA1c

A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.

05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
1,100 participants (estimated)

Study arms

  • Experimental
    Suzetrigine (SUZ)

    Participants will be randomized to receive SUZ.

    Drug: Suzetrigine · Drug: Placebo (matched to Pregabalin)

  • Active comparator
    Pregabalin

    Participants will be randomized to receive Pregabalin.

    Drug: Placebo (matched to SUZ) · Drug: Pregabalin

  • Placebo comparator
    Placebo

    Participants will be randomized to receive placebo matched to SUZ and Pregabalin.

    Drug: Placebo (matched to SUZ) · Drug: Placebo (matched to Pregabalin)

Interventions

  • Tablets for oral administration.

    Also known as: VX-548, SUZ

  • DrugPlacebo (matched to SUZ)

    Placebo matched to SUZ for oral administration.

  • Capsules for oral administration.

  • DrugPlacebo (matched to Pregabalin)

    Placebo matched to Pregabalin for oral administration.

06

What researchers measure

Primary outcomes

  1. Change From Baseline in the Weekly Average of Daily Pain Intensity on the Numeric Pain Rating Scale (NPRS) at Week 12 Compared to Placebo

    Time frame: From Baseline up to Week 12

Secondary outcomes

  1. Change From Baseline in the Medical Outcomes Study 36-item Short-form Health Status (SF 36v2) Physical Component Summary (PCS) Score at Week 12 Compared to Placebo (pooled with data from Study VX24-548-111)

    Time frame: From Baseline up to Week 12

  2. Change From Baseline in the Weekly Average of Daily Pain Intensity on the NPRS at Week 12 Compared to Pregabalin

    Time frame: From Baseline up to Week 12

07

Study locations

58 of 76 sites recruiting
  • Pinnacle Research Group, LLC
    Anniston, Alabama 36207, United States
    Recruiting
  • Synexus Clinical Research - Birmingham
    Birmingham, Alabama 35211, United States
    Completed

    Not enrolling at this site — choose another above.

  • AMR Daphne, AL
    Daphne, Alabama 36526, United States
    Completed

    Not enrolling at this site — choose another above.

  • Synexus Clinical Research - Phoenix Central
    Phoenix, Arizona 85020, United States
    Completed

    Not enrolling at this site — choose another above.

  • Scottsdale Clinical Trials
    Scottsdale, Arizona 85260, United States
    Recruiting
  • Neuro-Pain Medical Center
    Fresno, California 93710, United States
    Recruiting
  • Long Beach Research Institute
    Long Beach, California 90805, United States
    Recruiting
  • Angel City Research, Inc
    Los Angeles, California 90010, United States
    Recruiting
  • Empire Clinical Research
    Pomona, California 91767, United States
    Recruiting
  • Clinical Trials Research
    Sacramento, California 95821, United States
    Recruiting
  • Velocity Clinical Research, San Bernardino
    San Bernardino, California 92408, United States
    Recruiting
  • SCLA Management - Pain Management and Injury Relief
    Thousand Oaks, California 91320, United States
    Recruiting
  • Diablo Clinical Research (DCR)
    Walnut Creek, California 94598, United States
    Completed

    Not enrolling at this site — choose another above.

  • Velocity Clinical Research - Denver
    Englewood, Colorado 80110, United States
    Recruiting
  • Velocity Clinical Research - Washington DC
    Washington D.C., District of Columbia 20016, United States
    Recruiting
  • Accel Research - Deland
    DeLand, Florida 32720, United States
    Recruiting
  • AMR-Miami
    Doral, Florida 33172, United States
    Recruiting
  • AMR Fort Myers (The Clinical Study Center)
    Fort Myers, Florida 33912, United States
    Recruiting
  • Velocity Clinical Research - Hallandale Beach
    Hallandale, Florida 33009, United States
    Recruiting
  • CNS Healthcare - Jacksonville
    Jacksonville, Florida 32256, United States
    Recruiting
  • Accel Research - St. Petersburg-Largo
    Largo, Florida 33777, United States
    Recruiting
  • Accel Research - Maitland
    Maitland, Florida 32751, United States
    Completed

    Not enrolling at this site — choose another above.

  • Suncoast Research Associates - Miami
    Miami, Florida 33172, United States
    Recruiting
  • 3Sync Research - Miami Lakes
    Miami Lakes, Florida 33014, United States
    Recruiting
  • Suncoast Clinical Research - New Port Richey
    New Port Richey, Florida 34652, United States
    Recruiting
  • Synexus Clinical Research - Orlando
    Orlando, Florida 32806, United States
    Completed

    Not enrolling at this site — choose another above.

  • Conquest Clinical Research - Orlando - Neuro
    Orlando, Florida 32832, United States
    Recruiting
  • Conquest Clinical Research - Winter Park
    Winter Park, Florida 32789, United States
    Recruiting
  • Accel Research - Decatur
    Decatur, Georgia 30030, United States
    Recruiting
  • Velocity Clinical Research - Boise
    Meridian, Idaho 83642, United States
    Recruiting
  • Feinberg School of Medicine - Anesthesiology
    Chicago, Illinois 60611, United States
    Recruiting
  • Healthcare Research Network - Flossmoor IL
    Flossmoor, Illinois 604773027, United States
    Recruiting
  • Synexus Clinical Research - Evansville
    Evansville, Indiana 47714, United States
    Completed

    Not enrolling at this site — choose another above.

  • AMR Wichita East, KS (Heartland Research Associates)
    Wichita, Kansas 67207, United States
    Recruiting
  • AMR Lexington
    Lexington, Kentucky 40509, United States
    Recruiting
  • Velocity Clinical Research - Baton Rouge
    Baton Rouge, Louisiana 70809, United States
    Recruiting
  • Tandem Clinical Research- Covington
    Covington, Louisiana 70433, United States
    Recruiting
  • Mass General Brigham - Brigham and Women's Hospital - Main Campus
    Boston, Massachusetts 02115, United States
    Recruiting
  • MedVadis Research Corporation
    Waltham, Massachusetts 02451, United States
    Recruiting
  • Healthcare Research Network - Hazelwood MO
    Hazelwood, Missouri 63042, United States
    Recruiting
  • AMR Kansas City
    Kansas City, Missouri 64114, United States
    Recruiting
  • St. Louis Children's Hospital - Nephrology
    St Louis, Missouri 63110, United States
    Completed

    Not enrolling at this site — choose another above.

  • Synexus Clinical Research - St. Louis
    St Louis, Missouri 63141, United States
    Completed

    Not enrolling at this site — choose another above.

  • Velocity Clinical Research - Norfolk
    Norfolk, Nebraska 68701, United States
    Recruiting
  • Synexus Clinical Research - Las Vegas
    Las Vegas, Nevada 89113, United States
    Completed

    Not enrolling at this site — choose another above.

  • HRI - Hassman Research Institute
    Marlton, New Jersey 08053, United States
    Completed

    Not enrolling at this site — choose another above.

  • Velocity Clinical Research - Albuquerque
    Albuquerque, New Mexico 87107, United States
    Recruiting
  • Albany Medical College
    Albany, New York 12208, United States
    Completed

    Not enrolling at this site — choose another above.

  • Swift Clinical OpCo, Inc
    Brooklyn, New York 11226, United States
    Recruiting
  • Velocity Clinical Research - Syracuse
    East Syracuse, New York 13057, United States
    Recruiting
  • Synexus Clinical Research - New York (DRS)
    New York, New York 10017, United States
    Completed

    Not enrolling at this site — choose another above.

  • Columbia Presbyterian - The Neurological Institute of New York
    New York, New York 10032, United States
    Recruiting
  • West Clinical Research
    Morehead City, North Carolina 28557, United States
    Recruiting
  • Eximia Research - Raleigh
    Raleigh, North Carolina 27607, United States
    Recruiting
  • Carolinas Pain Institute - Winston-Salem Office
    Winston-Salem, North Carolina 27103, United States
    Recruiting
  • Velocity Clinical Research - Cleveland
    Beachwood, Ohio 44122, United States
    Recruiting
  • Synexus Clinical Research - Cincinnati
    Cincinnati, Ohio 45236, United States
    Completed

    Not enrolling at this site — choose another above.

  • META Medical Research Institute
    Dayton, Ohio 45432, United States
    Recruiting
  • Velocity Clinical Research - Grants Pass
    Grants Pass, Oregon 97527, United States
    Completed

    Not enrolling at this site — choose another above.

  • Velocity Clinical Research - Medford
    Medford, Oregon 97504, United States
    Recruiting
  • Suburban Research Associates - Media
    Media, Pennsylvania 19063, United States
    Recruiting
  • Velocity Clinical Research - Providence
    East Greenwich, Rhode Island 02818, United States
    Recruiting
  • Synexus Clinical Research- Anderson
    Anderson, South Carolina 29621, United States
    Completed

    Not enrolling at this site — choose another above.

  • Clinical Trials of South Carolina - Berkeley - Charleston
    Charleston, South Carolina 29406, United States
    Recruiting
  • M3 Wake Research - Charleston
    Charleston, South Carolina 29414, United States
    Recruiting
  • Velocity Clinical Research - Spartanburg
    Spartanburg, South Carolina 29303, United States
    Recruiting
  • AMR Nashville, TN
    Nashville, Tennessee 37203, United States
    Completed

    Not enrolling at this site — choose another above.

  • Zenos Clinical Research
    Dallas, Texas 75230, United States
    Recruiting
  • Synexus Clinical Research - Dallas (DFW) (DRS)
    Dallas, Texas 75234, United States
    Completed

    Not enrolling at this site — choose another above.

  • Be Well Clinical Studies - Austin
    Round Rock, Texas 78681, United States
    Recruiting
  • San Antonio Clinical Trials
    San Antonio, Texas 78240, United States
    Recruiting
  • Velocity Clinical Research - Waco
    Waco, Texas 76710, United States
    Recruiting
  • Velocity Clinical Research - Salt Lake City
    West Jordan, Utah 84088, United States
    Recruiting
  • Kalo Clinical Research - West Valley City
    West Valley City, Utah 84120, United States
    Recruiting
  • Dominion Medical Associates, Inc.
    Richmond, Virginia 23219, United States
    Recruiting
  • Northwest Clinical Research Center (NWCRC)
    Bellevue, Washington 98007, United States
    Recruiting
08

References and documents

Publications

  • Fensterwald M, Johnson J, Moreno A, Conger-Love S, Flippen C, Hesterman C, Johnston M, Kamins J, Minota K, Pak P, Hashim S, Huynh-Tran TL, Kobayashi N, Shane B, Charles A, Nwaobi S. Suzetrigine as a novel treatment for headache disorders: A case series. Headache. 2026 Jul-Aug;66(7):1644-1649. doi: 10.1111/head.70147. Epub 2026 Jun 5. PubMed 42249666 ↗

Individual participant data

Plan to share: No — Details on Vertex data sharing criteria and process for requesting access can be found at: https://www.vrtx.com/our-science/clinical-trials-data-sharing/

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2024 (actual). Primary completion is estimated for May 2027, 31 months after the start.

Of 33 phase 3 interventional studies under Neuralgia, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 42. This study's planned 31 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 30, 2024
First posted
Oct 8, 2024
StartActual
Oct 1, 2024
Primary completionEst.
May 31, 2027
CompletionEst.
May 31, 2027
Last update
Oct 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
St. Louis Children's Hospital - Nephrology is now Completed
Oct 15, 2026
Show all 1 update
  1. Oct 15, 2026
    St. Louis Children's Hospital - Nephrology is now Completed
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06628908
Responsible party
Sponsor
First posted
Oct 8, 2024
Start date
Oct 1, 2024
Primary completion
May 31, 2027 (estimated)
Completion
May 31, 2027 (estimated)
Last update
Oct 15, 2026

Study contacts

Medical Information
Contact
medicalinfo@vrtx.com
617-341-6777

Oversight

FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Suzetrigine

Start the discussion